<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32558369</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Spreading in ALS: The relative impact of upper and lower motor neuron involvement.</ArticleTitle><Pagination><StartPage>1181</StartPage><EndPage>1192</EndPage><MedlinePgn>1181-1192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51098</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To investigate disease spread in amyotrophic lateral sclerosis (ALS), and determine the influence of lower (LMN) and upper motor neuron (UMN) involvement.</AbstractText><AbstractText Label="METHODS">We assessed disease spread in ALS in 1376 consecutively studied patients, from five European centers, applying an agreed proforma to assess LMN and UMN signs. We defined the pattern of disease onset and progression from predominant UMN or lower motor neuron (LMN) dysfunction in bulbar, upper limbs, lower limbs, and thoracic regions Non-linear regression analysis was applied to fit the data to a model that described the relation between two random variables, graphically represented by an inverse exponential curve. We analyzed the probability, rate of spread, and both combined (area under the curve).</AbstractText><AbstractText Label="RESULTS">We found that progression was more likely and quicker to or from the region of onset to close spinal regions. When the disease had a limb onset, bulbar motor neurons were more resistant. Furthermore, in the same time frame more patients progressed from bulbar to lower limbs than vice-versa, whether predominantly UMN or LMN involvement. Patients with initial thoracic involvement had a higher probability for rapid change. The presence of predominant UMN signs was associated with a faster caudal progression.</AbstractText><AbstractText Label="INTERPRETATION">Contiguous progression was leading pattern, and predominant UMN involvement is important in shortening the time for cranial-caudal spread. Our results can best be fitted to a model of independent LMN and UMN degeneration, with regional progression of LMN degeneration mostly by contiguity. UMN lesion causes an acceleration of rostral-caudal LMN loss.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gromicho</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Physiology, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueiral</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>LASIGE, Departamento de Inform&#xe1;tica, Faculdade de Ci&#xea;ncias, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uysal</LastName><ForeName>Hilmi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6063-377X</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Clinical Neurophysiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuzma-Kozakiewicz</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurodegenerative Disease Research Group and Neurodegenerative Disease Research Group, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Susana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0727-5897</Identifier><AffiliationInfo><Affiliation>Institute of Physiology, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madeira</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>LASIGE, Departamento de Inform&#xe1;tica, Faculdade de Ci&#xea;ncias, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swash</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Physiology, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Neurology and Neuroscience, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Mamede</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7556-0158</Identifier><AffiliationInfo><Affiliation>Institute of Physiology, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences and Mental Health, Centro Hospitalar Universit&#xe1;rio de Lisboa-Norte, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>None of the authors disclose any conflict of interest concerning this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32558369</ArticleId><ArticleId IdType="pmc">PMC7359118</ArticleId><ArticleId IdType="doi">10.1002/acn3.51098</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007;68:1571&#x2013;1575.</Citation><ArticleIdList><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. The role of axonal transport in neurodegenerative disease spread: a meta&#x2010;analysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can J Neurol Sci / J Can des Sci Neurol 1991;18:435&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">1718581</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura&#x2010;Kiyono C, Kimura F, Ishida S, et al. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82:1244&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">21921087</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. Natural history of ALS:symptoms, strength, pulmonary function, and disability. Neurology 1996;47:71S&#x2013;82S.</Citation><ArticleIdList><ArticleId IdType="pubmed">8858055</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S, Kollewe K, Fahlbusch M, et al. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve 2011;43:636&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">21484822</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo&#x2010;Monachelli GM, Janota F, Bettini M, et al. Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol 2012;19:834&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Jin J, Jia R, et al. Spread direction and prognostic factors in limb&#x2010;onset sporadic amyotrophic lateral sclerosis. Eur Neurol 2016;75:244&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">27165107</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Verstraete E, van den Heuvel MP, et al. Patterns of symptom development in patients with motor neuron disease. Amyotroph Lateral Scler Front Degener 2018;19:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">29037065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiguchi T, Kanouchi T, Shibuya K, et al. Spreading of amyotrophic lateral sclerosis lesions&#x2013;multifocal hits and local propagation? J Neurol Neurosurg Psychiatry 2014;85:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24027298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince PG, Evans J, Knopp M, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve 1992;15:219&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">1549143</ArticleId></ArticleIdList></Reference><Reference><Citation>Swash M. Amyotrophic lateral sclerosis: a phylogenetic disease of the corticomotoneuron? Comments on the hypothesis. Muscle Nerve 1992;15:226&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">1549145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Ryczkowski A, Andersen P, et al. International survey of ALS experts about critical questions for assessing patients with ALS. Amyotroph Lateral Scler Front Degener 2017;18:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28705085</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Pinto S, Swash M. Association between paraspinal muscles and diaphragm denervation in ALS. Amyotr Lat Scler 2010;11:63&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">19533450</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R, Copetti M, Panza F, et al. Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study. Eur J Neurol 2016;23:1117&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">27016147</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Pinto A, De Carvalho M. Do bulbar&#x2010;onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal&#x2010;onset amyotrophic lateral sclerosis patients? Eura Medicophys 2007;43:505&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">18084174</ArticleId></ArticleIdList></Reference><Reference><Citation>Swash M. How does ALS spread between neurones in the CNS? J Neurol Neurosurg Psychiatry 2013;84:116&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">23033352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology 2009;73:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, &#xc4;ij&#xf6; T, Vickovic S, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 2019;364:89&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, et al. Amyotrophic lateral sclerosis&#x2014;a model of corticofugal axonal spread. Nat Rev Neurol 2013;9:708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Arai K, Del Tredici K, et al. TDP&#x2010;43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 2014;128:423&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku Y. Reappraisal of the anatomical spreading and propagation hypothesis about TDP&#x2010;43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neuropathology 2020; 10.1111/neup.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12644</ArticleId><ArticleId IdType="pubmed">32157757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>